ENTR1, located on chromosome 9, q34.3, was originally identified as an antigen in serum derived from colon cancer patients and was called serologically defined colon cancer antigen 3 (SDCCAG3) with two major splicing variants (37). Here, ENTR1 is linked to colonic neoplasm.